Affimed NV(AFMD)

0.1815+0.00000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Affimed N.V.5月19日成交额为451.02万美元
  市场透视 · 2025-05-20
  Affimed N.V.5月19日成交额为451.02万美元
- Affimed N.V.盘中异动大幅跳水24.34%
  市场透视 · 2025-05-19
  Affimed N.V.盘中异动大幅跳水24.34%
- Affimed N.V.盘中异动早盘股价大涨151.82%
  市场透视 · 2025-05-16
  Affimed N.V.盘中异动早盘股价大涨151.82%
- Affimed N.V.股价重挫19.23% 市值跌33.09万美元
  市场透视 · 2025-05-15
  Affimed N.V.股价重挫19.23% 市值跌33.09万美元
- Affimed N.V.股价重挫18.36% 市值跌32.92万美元
  市场透视 · 2025-05-14
  Affimed N.V.股价重挫18.36% 市值跌32.92万美元
- 富国银行：下调Affimed评级，由增持调整至持股观望评级, 目标价由11.00美元调整至0.10美元。
  金融界 · 2025-05-14
  富国银行：下调Affimed评级，由增持调整至持股观望评级, 目标价由11.00美元调整至0.10美元。
- Affimed N.V.盘中异动股价大跌6.19%
  市场透视 · 2025-05-07
  Affimed N.V.盘中异动股价大跌6.19%
- Affimed N.V.盘中异动早盘快速上涨5.66%
  市场透视 · 2025-05-06
  Affimed N.V.盘中异动早盘快速上涨5.66%
- Affimed N.V.盘中异动快速下跌6.36%报1.03美元
  市场透视 · 2025-05-02
  Affimed N.V.盘中异动快速下跌6.36%报1.03美元
- Affimed N.V.盘中异动大幅上涨5.53%
  市场透视 · 2025-05-01
  Affimed N.V.盘中异动大幅上涨5.53%
- Affimed N.V.盘中异动急速下挫5.97%报0.930美元
  市场透视 · 2025-04-30
  Affimed N.V.盘中异动急速下挫5.97%报0.930美元
- Affimed N.V.盘中异动股价大涨5.15%
  市场透视 · 2025-04-29
  Affimed N.V.盘中异动股价大涨5.15%
- Affimed N.V.盘中异动早盘股价大涨6.99%报1.000美元
  市场透视 · 2025-04-28
  Affimed N.V.盘中异动早盘股价大涨6.99%报1.000美元
- Affimed N.V.盘中异动急速上涨5.02%
  市场透视 · 2025-04-26
  Affimed N.V.盘中异动急速上涨5.02%
- Affimed N.V.盘中异动快速拉升5.14%
  市场透视 · 2025-04-22
  Affimed N.V.盘中异动快速拉升5.14%
- Affimed N.V.盘中异动早盘急速下挫5.37%
  市场透视 · 2025-03-06
  Affimed N.V.盘中异动早盘急速下挫5.37%
- Affimed N.V.盘中异动快速拉升5.42%
  市场透视 · 2025-03-06
  Affimed N.V.盘中异动快速拉升5.42%
- Affimed N.V.盘中异动快速下跌5.82%报0.970美元
  市场透视 · 2025-03-04
  Affimed N.V.盘中异动快速下跌5.82%报0.970美元
- Affimed N.V.盘中异动早盘大幅上涨5.25%报1.048美元
  市场透视 · 2025-02-27
  Affimed N.V.盘中异动早盘大幅上涨5.25%报1.048美元
- Affimed N.V.盘中异动急速上涨5.10%
  市场透视 · 2025-02-13
  Affimed N.V.盘中异动急速上涨5.10%
公司概况
公司名称
Affimed NV
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.affimed.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Affimed N.V.于2014年5月在荷兰成立成为了一家持股公司。该公司是一个临床阶段的生物制药公司，致力于发现和开发具有高度针对性的癌症免疫疗法。该公司的候选产品在免疫肿瘤领域的发展代表了癌症治疗，旨在利用人体自身的免疫系统来对抗肿瘤细胞的一种创新的方法。
- 2024-11-09
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-24
  超过5%披露
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
  Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 2024-03-28
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 2024-02-13
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 2023-03-23
  员工持股计划
  S-8 - Securities to be offered to employees in employee benefit plans
  S-8 - Securities to be offered to employees in employee benefit plans
- 2023-03-23
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2023-02-14
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
- 2023-02-14
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
- 2023-02-14
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
- 2023-02-14
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
- 2022-04-21
  超过5%披露
  SC 13G - Statement of acquisition of beneficial ownership by individuals
  SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2022-03-31
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-02-14
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
- 2022-02-14
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals

分时
5日
日
周
月

数据加载中...

最高

0.1815

今开

0.1815

量比

0.00

最低

0.1815

昨收

0.1815

换手率

0.00%

Affimed NV(AFMD)

公司概况

热议股票